News
In clinical trials, researchers found Yeztugo to be highly effective as a twice-yearly form of pre-exposure prophylaxis.
US regulators approved an HIV drug described as a “miracle” by the UN for its ability to prevent infections with two doses a ...
2d
IFLScience on MSNRevolutionary Drug That's “Closest Thing” To HIV Vaccine Gets FDA ApprovalThe breakthrough double injection won’t be cheap in the US, although scientists argue it could (and should) be.
The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported ...
“This is a historic day in the decades-long fight against HIV,” Gilead CEO Daniel O’Day said in the company’s announcement.
The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...
A drug called lenacapavir, administered in two injections a year, offers protection from HIV comparable to daily pills. One ...
The clearance ushers in a closely-watched launch for Gilead, which aims to show a long-acting injection can upend a market ...
The U.S. Food and Drug Administration has approved Yeztugo (lenacapavir), an injectable HIV-1 capsid inhibitor, as ...
15hon MSN
The FDA's approval of lenacapavir, a highly effective HIV prevention drug, sparks debate in India due to its high cost of ₹24 ...
The Food and Drug Administration (FDA) approved an injectable medication to be used as an HIV prevention drug on Wednesday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results